These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 25831677)

  • 21. Correlation of corneal complications with eyelid cicatricial pathologies in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis syndrome.
    Di Pascuale MA; Espana EM; Liu DT; Kawakita T; Li W; Gao YY; Baradaran-Rafii A; Elizondo A; Raju VK; Tseng SC
    Ophthalmology; 2005 May; 112(5):904-12. PubMed ID: 15878074
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of systemic immunomodulatory treatment and prognostic factors on chronic ocular complications in Stevens-Johnson syndrome.
    Kim DH; Yoon KC; Seo KY; Lee HS; Yoon SC; Sotozono C; Ueta M; Kim MK
    Ophthalmology; 2015 Feb; 122(2):254-64. PubMed ID: 25262319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prosthetic replacement of the ocular surface ecosystem as treatment for ocular surface disease in patients with a history of Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Papakostas TD; Le HG; Chodosh J; Jacobs DS
    Ophthalmology; 2015 Feb; 122(2):248-53. PubMed ID: 25282251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of Stevens-Johnson syndrome and toxic epidermal necrolysis in children.
    Prendiville JS; Hebert AA; Greenwald MJ; Esterly NB
    J Pediatr; 1989 Dec; 115(6):881-7. PubMed ID: 2585222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tear exchangeable limbal rigid contact lens for ocular sequelae resulting from Stevens-Johnson syndrome or toxic epidermal necrolysis.
    Sotozono C; Yamauchi N; Maeda S; Kinoshita S
    Am J Ophthalmol; 2014 Nov; 158(5):983-93. PubMed ID: 25036881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature.
    Letko E; Papaliodis DN; Papaliodis GN; Daoud YJ; Ahmed AR; Foster CS
    Ann Allergy Asthma Immunol; 2005 Apr; 94(4):419-36; quiz 436-8, 456. PubMed ID: 15875523
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The management of severe ocular complications of stevens-johnson syndrome and toxic epidermal necrolysis.
    Sotozono C; Ueta M; Kinoshita S
    Arch Dermatol; 2009 Nov; 145(11):1336-7; author reply 1337-8. PubMed ID: 19917974
    [No Abstract]   [Full Text] [Related]  

  • 28. 27 years of a single burn centre experience with Stevens-Johnson syndrome and toxic epidermal necrolysis: analysis of mortality risk for causative agents.
    Weinand C; Xu W; Perbix W; Lefering R; Maegele M; Rathert M; Spilker G
    Burns; 2013 Nov; 39(7):1449-55. PubMed ID: 23702222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnosis and treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis with ocular complications.
    Sotozono C; Ueta M; Koizumi N; Inatomi T; Shirakata Y; Ikezawa Z; Hashimoto K; Kinoshita S
    Ophthalmology; 2009 Apr; 116(4):685-90. PubMed ID: 19243825
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Ocular signs and results in Stevens-Johnson syndrome].
    Wang SC
    Zhonghua Yan Ke Za Zhi; 1984 May; 20(3):170-3. PubMed ID: 6439511
    [No Abstract]   [Full Text] [Related]  

  • 31. New grading system for the evaluation of chronic ocular manifestations in patients with Stevens-Johnson syndrome.
    Sotozono C; Ang LP; Koizumi N; Higashihara H; Ueta M; Inatomi T; Yokoi N; Kaido M; Dogru M; Shimazaki J; Tsubota K; Yamada M; Kinoshita S
    Ophthalmology; 2007 Jul; 114(7):1294-302. PubMed ID: 17475335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The current understanding of Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Mockenhaupt M
    Expert Rev Clin Immunol; 2011 Nov; 7(6):803-13; quiz 814-5. PubMed ID: 22014021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute respiratory failure in patients with toxic epidermal necrolysis: clinical features and factors associated with mechanical ventilation.
    de Prost N; Mekontso-Dessap A; Valeyrie-Allanore L; Van Nhieu JT; Duong TA; Chosidow O; Wolkenstein P; Brun-Buisson C; Maître B
    Crit Care Med; 2014 Jan; 42(1):118-28. PubMed ID: 23989174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Head and neck manifestations of erythema multiforme in children.
    Stewart MG; Duncan NO; Franklin DJ; Friedman EM; Sulek M
    Otolaryngol Head Neck Surg; 1994 Sep; 111(3 Pt 1):236-42. PubMed ID: 8084631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toxic epidermal necrolysis and Steven Johnson syndrome: 11-years experience and outcome.
    Gravante G; Delogu D; Marianetti M; Trombetta M; Esposito G; Montone A
    Eur Rev Med Pharmacol Sci; 2007; 11(2):119-27. PubMed ID: 17552141
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Study of the ocular findings in Stevens-Johnson syndrome patients from a tertiary ophthalmologic center].
    Franca MD; Lima JP; Freitas Dd; Cunha M; Gomes JA
    Arq Bras Oftalmol; 2009; 72(3):370-4. PubMed ID: 19668969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical manifestations and outcomes in 17 cases of Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Wong KC; Kennedy PJ; Lee S
    Australas J Dermatol; 1999 Aug; 40(3):131-4. PubMed ID: 10439522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Ocular involvement in Stevens-Johnson syndrome: treatment with amniotic membrane transplantation in the acute phase].
    Kardaun SH; Huei Liem K; Stoutenbeek R
    Ned Tijdschr Geneeskd; 2017; 161():D1739. PubMed ID: 29171370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute and Chronic Ophthalmic Involvement, Severity, and Sequelae in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
    Ganekal S; Nagarajappa A
    Korean J Ophthalmol; 2021 Jun; 35(3):179-187. PubMed ID: 33596622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute blistering diseases on the burn ward: Beyond Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
    Richer V; Bouffard D; Bélisle A; Duranceau L; Perreault I; Provost N
    Burns; 2013 Sep; 39(6):1290-6. PubMed ID: 23597847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.